Lottare GBM | LOcalized Targeted Therapy to Avoid REcurrent GlioBlastoma Multiforme 01-12-2019 - 31-05-2020 Show more information Organisation TARGTEX SA
nPL4GBM | Clinical validation of NANO-PL: a hydrogel-based formulation of a small molecule for a highly targeted therapy against Glioblastoma Multiforme (GBM) 01-11-2024 - 28-02-2026 Show more information Organisation TARGTEX SA